Time on boards
- Boards served
- 4
- Current seats
- 4
- Board service
- 15 years
- Director since
- 2023
15 years of board service in total across 4 boards, counting each seat separately. Longest: GridAI Technologies Corp., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
GT Biopharma Inc. August 14, 202679.6%
-
Eton Pharmaceuticals Inc. June 9, 202664.0%
-
GT Biopharma Inc. June 28, 202384.5%
-
GridAI Technologies Corp. June 22, 202375.9%
-
Eton Pharmaceuticals Inc. June 13, 202394.8%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Nov 10, 2026 | Eton Pharmaceuticals Inc. | Option exercise | +12,500 | $7.31 | $91,375 |
| Nov 10, 2026 | Eton Pharmaceuticals Inc. | Option exercise | +27,400 | $3.58 | $98,092 |
| Nov 10, 2026 | Eton Pharmaceuticals Inc. | Option exercise | +19,655 | $8.61 | $169,230 |
| Nov 10, 2026 | Eton Pharmaceuticals Inc. | Option exercise | +21,000 | $3.78 | $79,380 |
| Nov 10, 2026 | Eton Pharmaceuticals Inc. | Open-market sale | −6,380 | $64.33 | $410,417 |
| Nov 10, 2026 | Eton Pharmaceuticals Inc. | Open-market sale | −14,715 | $65.32 | $961,256 |
| Nov 10, 2026 | Eton Pharmaceuticals Inc. | Open-market sale | −22,601 | $66.26 | $1,497,576 |
| Nov 10, 2026 | Eton Pharmaceuticals Inc. | Open-market sale | −33,956 | $67.11 | $2,278,797 |
| Nov 10, 2026 | Eton Pharmaceuticals Inc. | Open-market sale | −2,903 | $67.87 | $197,025 |
| Oct 22, 2024 | Relmada Therapeutics Inc. | Gift | −13,000 | — | — |
| Sep 9, 2024 | Relmada Therapeutics Inc. | Open-market purchase | +13,000 | $2.56 | $33,280 |
| Jan 2, 2024 | GridAI Technologies Corp. | Grant or award | +19,633 | — | — |
| Sep 15, 2023 | GridAI Technologies Corp. | Open-market sale | −10 | $0.43 | $4 |
| Aug 31, 2023 | GridAI Technologies Corp. | Open-market sale | −6,053 | $0.30 | $1,816 |
| Jan 3, 2023 | GridAI Technologies Corp. | Grant or award | +84,745 | — | — |
Questions about Charles J. Casamento
What boards is Charles J. Casamento on?
Charles J. Casamento sits on the boards of Eton Pharmaceuticals Inc., GT Biopharma Inc., GridAI Technologies Corp. and Relmada Therapeutics Inc.
How long has Charles J. Casamento served on boards?
Our records show at least 15 years of board service across 4 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.